# OnCo record utsw-simmons (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/utsw-simmons/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "utsw-simmons" ;
  schema:name "Harold C. Simmons Comprehensive Cancer Center, UT Southwestern"@en ;
  schema:alternateName "Simmons Cancer Center"@en ;
  schema:description "North Texas's NCI comprehensive centre, where the HIF-2 inhibitor belzutifan, stereotactic body radiotherapy and the cGAS-STING pathway were born."@en ;
  schema:url <https://onco.cc/institutions/utsw-simmons/>, <https://www.utsouthwestern.edu/education/medical-school/departments/simmons/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.utsouthwestern.edu/education/medical-school/departments/simmons/> ;
  schema:addressCountry "US" ;
  schema:addressLocality "Dallas, TX" ;
  schema:latitude "32.813"^^xsd:decimal ;
  schema:longitude "-96.841"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:sections <https://onco.cc/fronts/radiation/> ;
  onco:technologies <https://onco.cc/technologies/sbrt/>, <https://onco.cc/technologies/sting-agonist/>, <https://onco.cc/technologies/metabolic-therapy/> ;
  onco:targets <https://onco.cc/targets/hif2a/> ;
  onco:drugs <https://onco.cc/drugs/belzutifan/> ;
  onco:companies <https://onco.cc/companies/merck/> ;
  onco:terms <https://onco.cc/terms/oligometastatic/> ;
  onco:people <https://onco.cc/people/robert-timmerman/> .